CD4 and osteoporosis: The obtained findings have suggested the potential of NLRC3 to attenuate osteoclastogenesis, thus promoting CD4+ T cell functions and their ability to recruit CD11bhiLy6Chi inflammatory monocytes into the bone marrow; thereby, restricting osteoporosis progression.